Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)

NCT00433888 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

179

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemodialysis Patients

Interventions

DRUG: R744
DRUG: R744

Sponsor

Chugai Pharmaceutical